Holy Name Press Releases

Holy Name Medical Center is Offering Next Generation Robotic Bronchoscopy for Early Diagnosis and Treatment of Lung Cancer

September 3, 2025

Holy Name Medical Center today announced that it is one of only a few health systems in New Jersey offering a cutting-edge robotic system that makes it easier to find and test small spots in the lungs that may be cancerous. The Galaxy System uses advanced 3D imaging to help doctors locate and navigate to lung nodules, which are small masses in the lungs often tested for cancer.

Lung cancer is the second most common cancer in the U.S. and the leading cause of cancer deaths in the country. One of the biggest challenges is accurately finding and sampling the smaller lung nodules, which can delay and complicate treatment.

The Galaxy System changes that with its Tool-in-Lesion Tomosynthesis (TiLT) technology, shown to:

• Achieve 100% successful navigation to lesions, which means it can accurately reach even the smallest spots on the lungs; as small as 2cm
• Achieve 100% tool-in-lesion accuracy, which means the device can successfully get the biopsy tool into the nodules
• Up to ~95% diagnostic yield.1 , meaning in 95% of cases, the tissue sample collected is accurate enough for doctors to determine if it is cancer or not

With its always-on-camera bronchoscope, direct visualization is enabled for the entire procedure, including the time of biopsy. The Galaxy System is the only bronchoscopy system of its kind with a single-use, disposable scope for each patient, which improves safety and reduces the risk of infection.

"This technology empowers us to confidently detect lung cancer earlier, ultimately saving more lives,” said Paul Han, MD, pulmonary medicine at Holy Name. “We understand the importance of continually evaluating and investing in technologies like the robotic navigated bronchoscopy system that enable our physicians to provide life-changing care and give additional hope and peace of mind to patients.”